Azopt 1 % Ophthalmic Suspension
RxNorm 213272
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 213272 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Azopt 1 % Ophthalmic Suspension.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
PSNPrescribable
Prescribable Name (PSN):
Azopt 1 % Ophthalmic Suspension
(Atom ID: 6398968)
SYPrescribable
Synonym (SY):
Azopt 1 % Ophthalmic Suspension
(Atom ID: 3264158)
SYPrescribable
Synonym (SY):
Azopt 10 mg/ML Ophthalmic Suspension
(Atom ID: 1170497)
SBDPrescribable
Semantic Branded Drug (SBD):
Brinzolamide 10 mg/ML Ophthalmic Suspension [Azopt]
(Atom ID: 1170495)
Patient Education
Brinzolamide Ophthalmic
Ophthalmic Brinzolamide is used to treat glaucoma, a condition that increases pressure in the eye and leads to vision loss. Brinzolamide is in a class of medications called carbonic anhydrase inhibitors. It decreases the pressure in the eye.
[Learn More]
* Please review the disclaimer below.